Related Experiment Video
Updated: Jun 25, 2025

09:29
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.5K
Concurrent transverse myelitis and acute inflammatory demyelinating polyneuropathy
Matthew Shrimpton1, Cameron Shaw2
1Neurology Department, Barwon Health, Geelong, Victoria, Australia m.shrimpton@deakin.edu.au.
BMJ Case Reports
|May 28, 2024
Summary
This case study details a patient with simultaneous transverse myelitis and acute inflammatory demyelinating polyneuropathy. Prompt treatment with immunotherapy led to significant clinical improvement.
Area of Science:
- Neurology
- Immunology
- Neuroinflammation
Background:
- Transverse myelitis (TM) and acute inflammatory demyelinating polyneuropathy (AIDP) are distinct inflammatory neurological disorders.
- Concurrent presentation of TM and AIDP is rare, posing diagnostic and therapeutic challenges.
Purpose of the Study:
- To describe a rare case of co-occurring transverse myelitis and acute inflammatory demyelinating polyneuropathy.
- To highlight diagnostic features and review treatment strategies for this combined condition.
Main Methods:
- Case report of a woman in her 40s presenting with neurological deficits.
- Utilized spinal imaging (MRI) and neurophysiology studies.
- Reviewed literature on TM and AIDP diagnosis and treatment.
Main Results:
- The patient presented with thoracic sensory symptoms and lower motor neuron weakness.
- Spinal MRI confirmed transverse myelitis; neurophysiology indicated acute inflammatory demyelinating polyneuropathy.
- The patient showed improvement following treatment with intravenous immunoglobulin and methylprednisolone.
Conclusions:
- Differentiating TM and AIDP relies on clinical presentation, neuroimaging, and neurophysiological findings.
- Combined TM and AIDP may require multimodal immunomodulatory treatment.
- Intravenous immunoglobulin and corticosteroids can be effective in managing concurrent TM and AIDP.

